ask="9.00"
ask_size="1100"
average_daily_volume="30179"
bid="7.37"
bid_size="11100"
book_value="3.34"
change="+0.13"
change_from_200_day_moving_average="1.26"
change_from_50_day_moving_average="2.93"
change_from_52_week_high="-1.96"
change_From_52_week_low="4.31"
change_in_percent="+1.69%"
close="7.83"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-2.26"
ebitda="-50.28M"
eps_estimate_current_year="-2.59"
eps_estimate_next_quarter="-0.62"
eps_estimate_next_year="-2.83"
ex_dividend_date="N/A"
float_shares="686000"
high="7.99"
high_52_weeks="9.79"
last_trade_date="1/11/2017"
last_trade_price="7.83"
last_trade_size="100"
last_trade_time="3:59pm"
low="7.23"
low_52_weeks="3.52"
market_capitalization="166.62M"
moving_average_200_day="6.57"
moving_average_50_day="4.90"
name="Nabriva Therapeutics AG - Ameri"
notes="N/A"
one_year_target_price="16.16"
open="7.70"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="+19.15%"
percent_change_from_50_day_moving_average="+59.86%"
percent_change_from_52_week_high="-20.00%"
percent_change_from_52_week_low="+122.44%"
previous_close="7.70"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="2.31"
price_per_sales="31.51"
revenue="5.20M"
shares_outstanding="21280000"
short_ratio="3.75"
stock_exchange="NMS"
symbol="NBRV"
volume="19331"
weeks_range_52="3.52 - 9.79"
